Cargando…
EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury
Influenza A virus (IAV) remains a major worldwide health threat, especially to high-risk populations, including the young and elderly. There is an unmet clinical need for therapy that will protect the lungs from damage caused by lower respiratory infection. Here, we analyzed the role of EMAPII, a st...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094359/ https://www.ncbi.nlm.nih.gov/pubmed/29910176 http://dx.doi.org/10.1016/j.ymthe.2018.05.017 |